| 000 | 01832 a2200481 4500 | ||
|---|---|---|---|
| 005 | 20250516051728.0 | ||
| 264 | 0 | _c20120120 | |
| 008 | 201201s 0 0 eng d | ||
| 022 | _a1557-3265 | ||
| 024 | 7 |
_a10.1158/1078-0432.CCR-11-0793 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aYau, Thomas | |
| 245 | 0 | 0 |
_aPhase I dose-finding study of pazopanib in hepatocellular carcinoma: evaluation of early efficacy, pharmacokinetics, and pharmacodynamics. _h[electronic resource] |
| 260 |
_bClinical cancer research : an official journal of the American Association for Cancer Research _cNov 2011 |
||
| 300 |
_a6914-23 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial, Phase I; Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAngiogenesis Inhibitors _xadministration & dosage |
| 650 | 0 | 4 |
_aCarcinoma, Hepatocellular _xblood |
| 650 | 0 | 4 | _aDisease-Free Survival |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aIndazoles |
| 650 | 0 | 4 |
_aLiver Neoplasms _xblood |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aPyrimidines _xadministration & dosage |
| 650 | 0 | 4 |
_aSulfonamides _xadministration & dosage |
| 650 | 0 | 4 |
_aalpha-Fetoproteins _xmetabolism |
| 700 | 1 | _aChen, Pei-Jer | |
| 700 | 1 | _aChan, Pierre | |
| 700 | 1 | _aCurtis, C Martin | |
| 700 | 1 | _aMurphy, Philip S | |
| 700 | 1 | _aSuttle, A Benjamin | |
| 700 | 1 | _aGauvin, Jennifer | |
| 700 | 1 | _aHodge, Jeffrey P | |
| 700 | 1 | _aDar, Mohammed M | |
| 700 | 1 | _aPoon, Ronnie T | |
| 773 | 0 |
_tClinical cancer research : an official journal of the American Association for Cancer Research _gvol. 17 _gno. 21 _gp. 6914-23 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1158/1078-0432.CCR-11-0793 _zAvailable from publisher's website |
| 999 |
_c21076506 _d21076506 |
||